ZeroStack Corp.
ZSTKZeroStack Corp. in brief
ZeroStack Corp. is a listed company in the Pharmaceutical industry, based in the USA. Its market value was $51 M on 30 October 2026, which makes it the 21,187th largest listed company in the world and the 3,844th largest in the USA on this site. In the year to December 2025 it had sales of $36 M and a net loss of $120 M. It employs about 21 people. Its shares trade under the symbol ZSTK (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About ZeroStack Corp.
ZeroStack Corp. (formerly Flora Growth Corp.) was incorporated as Flora Growth Corp. on March 13, 2019, under the laws of the Province of Ontario. On January 29, 2026, the Company changed its corporate name from "Flora Growth Corp." to "ZeroStack Corp." and changed its Nasdaq ticker from "FLGC" to "ZSTK". We are a decentralized AI treasury and AI-focused asset management company that is investing in the future of AI. Our first AI-oriented project is through strategic ownership in 0G Tokens (as defined below). The Company is a global pharmaceutical distributor through its wholly owned subsidiary Phatebo GmbH.
ZeroStack Corp. timeline
- 2019
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2021
- 🔔· approximateInitial public offering on Nasdaq
- 🔔Initial public offering as Flora Growth Corp.Final prospectus filed with the SEC on 12 May 2021; shares registered for exchange trading on 10 May 2021.
- 2023
- 💰Record revenue of $76 millionFY2023, the highest of the 5 years on record.
- 2026
- ✎Renamed ZeroStack Corp.Formerly Flora Growth Corp..
Events of ZeroStack Corp. from SEC EDGAR, the company record and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,321 (Jan 2022) · #5,242 (Dec 2022) · #5,252 (Jul 2023) · #4,499 (Jan 2024) · #3,848 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 1.3×
- Price / book
- 0.7×
- Free cash flow yield
- -17.2%
- Net margin (TTM)
- -444.3%
- Operating margin
- -433.4%
- Return on equity
- -252.1%
- Liabilities / assets
- 45.8%
- Net debt
- $48M
- Revenue growth
- -0.5%
- R&D / revenue
- 1.2%
- Revenue per employee
- $1.7 M
- Profit per employee
- $-5.7 M
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $36M | -0.5% | $-155M | $-120M | -335.6% |
| Dec 2024 | $36M | -52.9% | $-9M | $-16M | -44.4% |
| Dec 2023 | $76M | +127.8% | $-50M | $-57M | -75.0% |
| Dec 2022 | $33M | +271.9% | $-47M | $-52M | -156.9% |
| Dec 2021 | $9M | — | $-19M | $-21M | -237.9% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-9M | $0M | $-9M | $-43.49 | — |
| Dec 2024 | $-5M | $0M | $-5M | $-50.02 | — |
| Dec 2023 | $-8M | $0M | $-9M | $-7.75 | — |
| Dec 2022 | $-16M | $1M | $-17M | $-13.68 | — |
| Dec 2021 | $-21M | $4M | $-25M | — | — |
Quarterly results
Latest quarter to Jun 2026: revenue $14M (+40.7% on a year earlier), net income $-25M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Nov 12, 20268-KCurrent reportAuditor change
- Nov 9, 20268-KCurrent reportMaterial agreement
- Nov 2, 20268-KCurrent reportMaterial agreement · Agreement ended · Directors or officers changed
- Aug 21, 20268-KCurrent reportOther events
- Aug 19, 20268-KCurrent reportMaterial agreement · Acquisition or disposal completed · Unregistered share sale · Directors or officers changed
- Jul 31, 202610-QQuarterly report · period to Jun 2026
- Jul 23, 20268-KCurrent reportAcquisition or disposal completed
- Jul 20, 20268-KCurrent reportDirectors or officers changed · Bylaws amended · Shareholder vote
- May 6, 20268-KCurrent reportDirectors or officers changed
- May 4, 202610-QQuarterly report · period to Mar 2026
- Mar 31, 20268-KCurrent reportMaterial agreement · Agreement ended · Unregistered share sale
- Feb 27, 202610-KAnnual report · period to Dec 2025
Official filings of ZeroStack Corp. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $36 M
- Operating income
- $-155 M
- Net income
- $-120 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $130 M
- Total liabilities
- $60 M
- Total equity
- $71 M
As of December-2025
Top 17 institutional investors in ZeroStack Corp.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 125,886 | New | 0.72% | $1 M | Nov 16, 2026 |
| 2 | Vanguard Capital Management LLC | 92,907 | New | 0.53% | $0 M | Nov 13, 2026 |
| 3 | Geode Capital Management, LLC | 49,399 | New | 0.28% | $0 M | Nov 6, 2026 |
| 4 | Vanguard Fiduciary Trust Co | 38,323 | New | 0.22% | $0 M | Nov 13, 2026 |
| 5 | Bolton Securities Corporation | 26,923 | New | 0.15% | $0 M | Nov 12, 2026 |
| 6 | State Street Corp | 13,437 | New | 0.08% | $0 M | Nov 12, 2026 |
| 7 | Northern Trust Corp | 11,281 | New | 0.06% | $0 M | Nov 16, 2026 |
| 8 | UBS Group AG | 4,169 | New | 0.02% | $0 M | Nov 10, 2026 |
| 9 | Citigroup Inc | 2,930 | New | 0.02% | $0 M | Nov 4, 2026 |
| 10 | Tower Research Capital LLC (TRC) | 948 | New | 0.01% | $0 M | Nov 16, 2026 |
| 11 | Caitong International Asset Management Co., Ltd | 15 | New | 0.00% | $0 M | Oct 29, 2026 |
| 12 | Royal Bank Of Canada | 12 | New | 0.00% | $0 M | Nov 16, 2026 |
| 13 | Northwestern Mutual Wealth Management Co | 12 | New | 0.00% | $0 M | Nov 13, 2026 |
| 14 | Osaic Holdings, Inc. | 12 | New | 0.00% | $0 M | Nov 12, 2026 |
| 15 | SBI Securities Co., Ltd. | 10 | New | 0.00% | $0 M | Oct 22, 2026 |
| 16 | Morgan Stanley | 7 | New | 0.00% | $0 M | Nov 13, 2026 |
| 17 | Key Financial Inc | 1 | New | 0.00% | $0 M | Nov 2, 2026 |
Insider trading at ZeroStack Corp.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Rudy RongPresident | Sell | -1,000 | $7.570 | $8 K | 0 | Form 4 |
| filed | Michael HeinrichExecutive Chairman, Director | Buyindirect | +4.61 M | $0.750 | $3.5 M | 4.61 M | Form 4 |
| filed | Daniel Reis-FariaCEO, Director | Exercise of in-the-money derivative | +5.95 M | — | — | 5.95 M | Form 4 |
| filed | Edward WooDirector | Grant or award | +50,000 | — | — | 134,698 | Form 4 |
| filed | Clifford StarkeCEO, Director | Grant or award | +900,000 | — | — | 906,846 | Form 4 |
| filed | Sammy DorfExecutive Chairman, Director | Grant or award | +250,000 | — | — | 250,000 | Form 4 |
| filed | Clifford StarkeCEO, Director | Buy | +6,795 | $0.950 | $6 K | 6,846 | Form 4 |
| filed | Harold WolkinDirector | Buy | +5,000 | $0.960 | $5 K | 5,000 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: ZeroStack Corp.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q4 2023 | Q4 2023 | $0M |
| Q3 2023 | Q3 2023 | $0M |
| Q4 2022 | Q4 2022 | $0M |
| Q3 2022 | Q3 2023 | $0M |
Trading halts
- 2026-08-25 13:38 UTC, code LUDP, resumed 13:43 UTC
- 2026-08-21 14:44 UTC, code LUDP, resumed 14:54 UTC
- 2026-08-20 13:32 UTC, code LUDP, resumed 13:46 UTC
- 2026-08-19 15:50 UTC, code LUDP, resumed 16:00 UTC
- 2026-08-19 15:45 UTC, code LUDP, resumed 15:50 UTC
Fails to deliver
- : 840 shares at $2.93
- : 113 shares at $4.00
- : 116 shares at $4.22
- : 4,345 shares at $4.05
- : 156 shares at $4.64
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
ZeroStack Corp. scorecard#
Passes 4 of the 18 checks that could be worked out: strongest in financial health (2 of 4), weakest in growth (0 of 4). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation2 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✓Price to book below its peers' median0.7×Price to book 0.7× against Pharmaceutical's median of 3.2×.
- ✓Price to sales below its peers' median1.3×Price to sales 1.3× against Pharmaceutical's median of 3.5×.
- ✗Free cash flow yield above 5%-17.2%Free cash flow is -17.2% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth0 of 4
- ✗Revenue grew in the newest year-0.5%Revenue down 0.5% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years2.2%2.2% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median2.2%2.2% a year against Pharmaceutical's median of 2.5% (65 companies).
- ✗Earnings per share grew in the newest year-43.49 vs -50.02Diluted EPS -43.49 in fiscal 2025 against -50.02 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 5
- ✗Profitable in the newest year-$120 MNet income -$120 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-433.4%-433.4% against Pharmaceutical's median of 1.8% (74 companies).
- ✗Return on equity above 15%-319.0%-319.0% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-433.4%-433.4% in fiscal 2025 against -141.4% in 2022.
Financial health2 of 4
- ✓Short-term assets cover short-term liabilities1.0×Current ratio 1.01 at the end of fiscal 2025.
- ✓Debt below equity0.8×Debt to equity 0.76 at the end of fiscal 2025.
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-6.11Z-score -6.11 (distress zone) for fiscal 2025.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from ZeroStack Corp.'s statements, beside the median of Pharmaceutical.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -433.4% | 1.8% | |
| Net margin | -335.6% | -1.5% | |
| Return on equity | -319.0% | -0.9% | |
| Revenue growth, 3 years a year | 2.2% | 2.5% | |
| Revenue growth | -0.5% | 7.3% | |
| Debt to equity | 0.76× | 0.66× |
1of 9on the Piotroski tests of financial strength
- Revenue fell 0.5% against the year before.
- Net loss of $120 million, the 5th loss-making year in a row.
- Free cash flow was negative: -$9 million.
ZeroStack Corp.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 36−0.5%100% | 36r60−52.9%100% | 76+128%100% | 33r37+272%100% | 9.0+8372%100% | 0.1—100% | — | |
| Cost of revenue | 34+1.1%95.4% | 34r47−42.3%93.9% | 58+189%76.7% | 20r23+207%60.3% | 6.6r6.6+18629%73.0% | 0.0—33.0% | — | |
| Gross profit | 1.6−24.9%4.6% | 2.2r12−87.6%6.1% | 18+33.9%23.3% | 13r14+446%39.7% | 2.4+3315%27.0% | 0.1—67.0% | — | |
| Research and development | — | 0.4+574%1.2% | 0.1−84.0%0.1% | 0.4r0.4+194%1.2% | 0.1+69.2%1.5% | 0.1—73.6% | — | |
| Selling, general and administrative | — | — | — | — | 4.5+222%50.2% | 1.4—1321% | — | |
| General and administrative | 1.4−27.9%3.9% | 1.9r1.9+17.2%5.4% | 1.6−49.9%2.2% | 3.3r4.5+257%9.8% | 0.9—10.3% | — | — | |
| Operating expenses | 156+1305%438% | 11r28−83.7%31.0% | 68+12.6%89.5% | 60r68+182%181% | 21—239% | — | — | |
| Operating income | −155—−433% | −8.9r−16—−24.9% | −50—−66.2% | −47r−53—−141% | −19—−212% | — | — | |
| Interest expense and finance costs | — | — | — | — | 0.1+180%0.9% | 0.0—28.3% | — | |
| Net interest income | −0.2—−0.7% | −0.2—−0.6% | −0.1−268%−0.1% | 0.1r−0.1+75.0%0.2% | 0.0—0.4% | — | — | |
| Income before tax | −115—−323% | −9.3r−16—−26.0% | −48—−63.5% | −48r−54—−144% | −21—−239% | −14—−13523% | −2.8—— | |
| Income tax | 0.1+168%0.2% | 0.0r−0.2—0.1% | −1.6—−2.1% | −1.4r−1.5—−4.2% | −0.1—−1.1% | 0—0.0% | 0—— | |
| Income from continuing operations | −115—−323% | −9.3r−16—−26.1% | −47—−61.3% | −47—−140% | — | — | — | |
| Income from discontinued operations | −4.3—−12.1% | −6.6r0—−18.3% | −9.7—−12.7% | −5.9—−17.7% | — | — | — | |
| Net income including minority interests | −120—−336% | −16—−44.4% | −56—−74.1% | −53r53−346%−158% | 21r−21—238% | −14—−13523% | — | |
| Minority interests' share of net income | — | 0−100%0.0% | 0.7—0.9% | −0.2—−0.6% | — | — | — | |
| Net income attributable to shareholders | — | −16—−44.4% | −57—−75.0% | −52r−53—−157% | −21—−238% | — | — | |
| Earnings per share, basic | -43.49—— | -50.02r-1.30—— | -7.75—— | -13.68—— | -0.48—— | -0.47—— | — | |
| Earnings per share, diluted | -43.49—— | -50.02r-1.30—— | -7.75—— | -13.68—— | — | — | — | |
| Shares, weighted average (basic) | 0.0+766%— | 0.0r0.0−95.7%— | 0.0+92.0%— | 0.0−91.3%— | 0.0+47.0%— | 0.0—— | — | |
| Shares, weighted average (diluted) | 0.0+766%— | 0.0r0.0−95.7%— | 0.0+92.0%— | 0.0—— | — | — | — | |
| Balance sheet | ||||||||
| Cash and cash equivalents | 5.6+7.1%4.3% | 5.2r6.0+20.1%19.9% | 4.4−51.3%18.4% | 8.9r9.5−76.2%11.0% | 38+142%44.0% | 16+10988%79.8% | 0.1—— | |
| Short-term investments | — | — | — | — | 2.7—3.1% | 0—0.0% | — | |
| Receivables | 0.8−49.0%0.6% | 1.6r3.1−60.3%6.0% | 4.0−24.9%16.7% | 5.3r6.9−1.2%6.5% | 5.3+477%6.2% | 0.9—4.7% | — | |
| Inventory | 1.9−15.3%1.5% | 2.2r5.8−73.7%8.5% | 8.5−2.7%36.0% | 8.7r10+189%10.8% | 3.0r3.0+461%3.5% | 0.5—2.8% | — | |
| Other current assets | 0.3+2385%0.2% | 0.0r0.6−99.0%0.0% | 1.4+69.9%5.8% | 0.8r1.0−52.6%1.0% | 1.7—2.0% | — | — | |
| Current assets | 8.7−55.9%6.7% | 20−7.5%75.4% | 21−31.4%90.4% | 31−35.0%38.5% | 48+172%56.1% | 18—90.7% | — | |
| Property, plant and equipment | 0.1+58.0%0.1% | 0.1r0.3−90.4%0.3% | 0.8−30.5%3.6% | 1.2r4.8−67.5%1.5% | 3.8+812%4.4% | 0.4—2.1% | — | |
| Right-of-use (leased) assets | 0.4+122%0.3% | 0.2r1.3−55.3%0.7% | 0.4−81.6%1.6% | 2.1r2.5+72.3%2.6% | 1.2+286%1.4% | 0.3—1.6% | — | |
| Goodwill | — | 2.0—7.6% | 0−100%0.0% | 23+18.8%28.9% | 20r20+4476%23.0% | 0.4r0.4—2.2% | — | |
| Other intangible assets | — | 2.7+190%10.5% | 0.9−94.7%4.0% | 18r18+82.2%21.9% | 9.7+1380%11.4% | 0.7—3.4% | — | |
| Long-term investments | — | 0—0.0% | 0−100%0.0% | 0.7—0.9% | — | — | — | |
| Total assets | 130+397%100% | 26+11.0%100% | 24−70.8%100% | 81−5.3%100% | 85+339%100% | 19—100% | — | |
| Accounts payable | 2.3−34.8%1.8% | 3.6r5.5−30.1%13.6% | 5.1−34.7%21.6% | 7.8r7.7+224%9.7% | 2.4r5.6+33.5%2.8% | 1.8—9.3% | — | |
| Debt due within a year | 2.7+30.9%2.1% | 2.1+7.7%7.9% | 1.9+77.8%8.2% | 1.1+5933%1.3% | 0.0—0.0% | — | — | |
| Current liabilities | 8.6−54.2%6.6% | 19+15.7%71.8% | 16−6.7%68.9% | 17+185%21.5% | 6.1+123%7.2% | 2.7—14.1% | — | |
| Long-term debt | 51—39.0% | 0—0.0% | — | — | — | — | — | |
| Lease liabilities (non-current) | 0.3+129%0.2% | 0.1r2.0−87.0%0.5% | 0.9−39.7%4.0% | 1.6r1.9+71.9%1.9% | 0.9r0.4+1064%1.1% | 0.1—0.4% | — | |
| Total liabilities | 60+175%45.8% | 22+26.1%82.8% | 17−29.9%72.9% | 25+188%30.3% | 8.5+167%10.0% | 3.2—16.5% | — | |
| Retained earnings | −278—−213% | −158—−603% | −143—−603% | −91—−112% | −39—−45.1% | −17—−88.9% | — | |
| Shareholders' equity | 71+1464%54.2% | 4.5−29.6%17.2% | 6.4−88.7%27.1% | 57−26.4%70.2% | 77—90.3% | — | — | |
| Minority interests | — | — | 0—0.0% | −0.4—−0.5% | −0.2—−0.3% | −0.1—−0.6% | — | |
| Total equity | 71+1464%54.2% | 4.5−29.6%17.2% | 6.4−88.6%27.1% | 56−26.7%69.7% | 77+373%90.0% | 16—83.5% | −1.3—— | |
| Total liabilities and equity | 130+397%100% | 26+11.0%100% | 24−70.8%100% | 81−5.3%100% | 85+339%100% | 19—100% | — | |
| Shares outstanding | 1.0+119%— | 0.5r19−94.7%— | 8.9+31.9%— | 6.8r0.1+10242%— | 0.1—— | — | — | |
| Cash-flow statement | ||||||||
| Depreciation and amortization | 0.6−24.2%1.6% | 0.8−69.1%2.1% | 2.5−5.5%3.3% | 2.6+425%7.9% | 0.5r0.8+343%5.6% | 0.1—107% | — | |
| Share-based compensation | 1.2−56.5%3.4% | 2.8+74.7%7.7% | 1.6−53.3%2.1% | 3.4+154%10.2% | 1.3—14.9% | — | — | |
| Cash from operating activities | −8.7—−24.3% | −5.0—−14.0% | −8.4—−11.0% | −16—−47.7% | −21r−21—−233% | −8.4—−7944% | — | |
| Capital expenditure | −0.1—−0.4% | −0.1—−0.4% | −0.2—−0.2% | −1.3—−3.9% | −4.0r−2.5—−44.4% | 0—0.0% | — | |
| Acquisitions, net of cash acquired | −0.5—−1.3% | −0.1—−0.2% | 0—0.0% | −15—−43.4% | −8.1—−90.1% | — | — | |
| Cash from investing activities | −3.5−1803%−9.7% | 0.2—0.6% | −0.2—−0.3% | −16—−47.3% | −15—−162% | −2.2—−2042% | — | |
| Debt issued | 2.8−66.7%7.9% | 8.4+745%23.4% | 1.0+405%1.3% | 0.2—0.6% | 0−100%0.0% | 0.0—5.7% | — | |
| Debt repaid | −2.4—−6.6% | −8.1—−22.7% | −0.2—−0.2% | −0.2—−0.6% | −0.3r−0.3—−3.4% | −1.0—−958% | — | |
| Shares issued | 16+114%45.0% | 7.5+174%20.9% | 2.7−45.2%3.6% | 5.0r4.6−88.3%15.0% | 43—475% | — | — | |
| Shares bought back | — | — | 0—0.0% | −0.3—−0.8% | 0—0.0% | — | — | |
| Cash from financing activities | 11+74.7%31.8% | 6.5+106%18.1% | 3.2−28.6%4.1% | 4.4−92.4%13.2% | 58r58+126%650% | 26—24355% | — | |
| Exchange-rate effect on cash | — | — | — | — | −0.8−638%−9.1% | 0.2—143% | — | |
| Change in cash | 0.4−77.6%1.0% | 1.7—4.6% | −4.6—−6.0% | −28−227%−84.1% | 22r22+43.6%246% | 15—14512% | — | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 20-F/A | 20-F/A | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Jun 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 | Q3 FY2023to Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 40+27.3%100% | 14+40.7%100% | 7.3+5.9%100% | 9.4*+22.3%100% | 9.7+34.7%100% | 9.7r15−38.1%100% | 6.9r12−61.9%100% | 7.6r13*−57.5%100% | 7.2r12−58.2%100% | 16—100% | 18—100% | 18*—100% | 17—100% | |
| Cost of revenue | 35+17.8%86.9% | 12+32.5%88.2% | 4.1−34.8%56.8% | 9.2*+24.9%98.3% | 9.4+39.6%96.6% | 9.1r12−27.4%93.6% | 6.3r8.9−55.3%92.2% | 7.4r11*−49.2%96.3% | 6.7r9.6−45.5%93.2% | 13—79.8% | 14—78.6% | 14*—80.6% | 12—71.5% | |
| Gross profit | 5.3+172%13.1% | 1.6+161%11.8% | 3.1+488%43.2% | 0.2*−44.1%1.7% | 0.3−32.3%3.4% | 0.6r2.8−80.5%6.4% | 0.5r2.9−86.1%7.8% | 0.3r2.6*−91.8%3.7% | 0.5r2.8−90.0%6.8% | 3.2—20.2% | 3.9—21.4% | 3.5*—19.4% | 4.9—28.5% | |
| Research and development | — | — | — | — | — | 0.1+17.7%0.8% | 0.1+140%1.6% | 0.2*+664%2.5% | 0.1+1375%1.6% | 0.1—0.4% | 0.0—0.3% | 0.0*—0.1% | 0.0—0.0% | |
| General and administrative | — | — | — | 0.3*−70.2%3.5% | 0.5+15.6%4.9% | 0.8+29.5%7.8% | 0.5+6.3%6.8% | 1.1r0.5*+310%14.5% | 0.4r0.4+20.3%5.7% | 0.6—3.7% | 0.4—2.5% | 0.3*—1.5% | 0.3—2.0% | |
| Operating expenses | 245+2147%611% | 26+1111%189% | 66+2955%905% | 149*+3645%1597% | 3.6+37.9%36.9% | 2.1r5.4−68.2%22.0% | 2.2r3.9−66.0%31.4% | 4.0r8.6*−63.3%52.2% | 2.6r6.5−52.4%36.1% | 6.7—42.8% | 6.3—35.2% | 11*—60.5% | 5.5—31.7% | |
| Operating income | −239—−598% | −24—−177% | −63—−861% | −149*—−1596% | −3.3—−33.5% | −1.5r−2.6—−15.6% | −1.6r−1.0—−23.6% | −3.7r−5.9*—−48.4% | −2.1r−3.7—−29.2% | −3.5—−22.6% | −2.5—−13.8% | −7.4*—−41.1% | −0.5—−3.1% | |
| Interest expense and finance costs | — | 0.1*−7.3%0.7% | 0.1+29.4%0.9% | — | 0.1*—0.6% | 0.1*—1.0% | 0.1—0.7% | — | — | — | — | — | — | |
| Net interest income | −0.3—−0.7% | −0.1—−0.7% | −0.1—−0.9% | −0.1*—−0.8% | −0.1—−0.6% | −0.1r−0.1−420%−0.8% | −0.0r−0.1—−0.3% | −0.2r−0.2*—−2.5% | −0.0—−0.4% | 0.0—0.2% | −0.0—−0.1% | −0.0*—−0.1% | −0.0*—−0.1% | |
| Income before tax | −175—−436% | −24—−178% | −37—−504% | −110*—−1176% | −3.6—−37.0% | −1.5r−2.5—−15.8% | −0.3r−0.7—−3.7% | −3.9r−6.2*—−50.4% | −2.4r−4.0−513%−33.0% | −2.7—−17.2% | −3.2—−18.0% | −7.5*—−41.7% | 0.6—3.3% | |
| Income tax | 0.2—0.5% | 0.3+3586%1.9% | −0.0−110%−0.1% | −0.1*—−0.6% | 0.0—0.2% | 0.0r−0.0—0.1% | 0.1r0.0−31.3%1.3% | −0.1r−0.1*—−0.8% | −0.1r−0.2—−0.9% | −0.0—−0.2% | 0.1—0.7% | −0.4*—−2.1% | −0.1—−0.3% | |
| Income from continuing operations | −175—−437% | −25—−180% | −37—−504% | −110*—−1175% | −3.6—−37.2% | −1.5r−2.4—−15.9% | −0.3r−0.8—−5.0% | −3.8r−6.1*—−49.7% | −2.3r−3.8−469%−32.1% | −2.7—−16.9% | −3.4—−18.7% | −7.1*—−39.6% | 0.6—3.6% | |
| Income from discontinued operations | −3.0—−7.6% | 0—0.0% | 0—0.0% | 0*—0.0% | −3.0—−31.1% | −0.9—−9.0% | −0.4—−6.1% | −2.3r0*—−29.8% | −1.5r0−400%−20.4% | 0—0.0% | 0—0.0% | −1.9*—−10.5% | 0.5—2.8% | |
| Net income including minority interests | −178—−444% | −25—−180% | −37—−504% | −110*—−1175% | −6.7—−68.3% | −2.4—−24.8% | −0.8—−11.0% | −6.1*—−79.5% | −3.8−439%−52.5% | −2.7—−16.9% | −3.4—−18.7% | −9.0*—−50.1% | 1.1—6.5% | |
| Minority interests' share of net income | — | — | — | — | 0—0.0% | 0—0.0% | — | 0.1*−95.1%0.7% | −0.0—−0.4% | −0.0—−0.2% | 0—0.0% | 1.1*—6.1% | −0.1—−0.7% | |
| Net income attributable to shareholders | — | — | — | — | −6.7—−68.3% | −2.4—−24.8% | — | −6.1*—−80.2% | −3.8−405%−52.1% | −2.6—−16.8% | −3.4—−18.7% | −10*—−56.2% | 1.2—7.1% | |
| Earnings per share, basic | — | -2.47—— | -3.68—— | — | -9.05—— | -4.27r-0.11—— | -1.54r-0.04—— | — | -11.03r-0.28−6228%— | -0.21—— | -0.38—— | — | 0.18—— | |
| Earnings per share, diluted | — | -2.47—— | -3.68—— | — | -9.05—— | -4.27r-0.11—— | -1.54r-0.04—— | — | -11.03r-0.28−6994%— | -0.21—— | -0.38—— | — | 0.16—— | |
| Shares, weighted average (basic) | 0.0+1663%— | 0.0+1663%— | 0.0+1924%— | — | 0.0+115%— | 0.0r0.0−95.4%— | 0.0r0.0−94.5%— | — | 0.0r0.0−95.1%— | 0.0—— | 0.0—— | — | 0.0—— | |
| Shares, weighted average (diluted) | 0.0+1663%— | 0.0+1663%— | 0.0+1924%— | — | 0.0+115%— | 0.0r0.0−95.4%— | 0.0r0.0−94.5%— | — | 0.0r0.0−95.5%— | 0.0—— | 0.0—— | — | 0.0—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 2.6—10.5% | 2.6+79.5%10.5% | 2.0−46.2%4.4% | 5.6+7.1%4.3% | 13+211%17.7% | 1.5−76.0%6.5% | 3.7−11.5%16.4% | 5.2r6.0+20.1%19.9% | 4.2−11.6%14.4% | 6.1—20.4% | 4.2—17.1% | 4.4—18.4% | 4.8—15.1% | |
| Receivables | 0.9—3.7% | 0.9−81.8%3.7% | 0.8−80.7%1.7% | 0.8−49.0%0.6% | 2.3−41.6%3.1% | 5.1+55.1%22.4% | 4.0+25.8%18.1% | 1.6r3.1−60.3%6.0% | 3.9+10.7%13.4% | 3.3—10.9% | 3.2—13.3% | 4.0—16.7% | 3.5—11.2% | |
| Inventory | 1.6—6.4% | 1.6−66.6%6.4% | 1.6−66.4%3.6% | 1.9−15.3%1.5% | 2.5−68.4%3.4% | 4.8−28.8%21.2% | 4.8−48.2%21.4% | 2.2r5.8−73.7%8.5% | 7.9−26.1%26.8% | 6.7—22.4% | 9.2—38.1% | 8.5—36.0% | 11—33.7% | |
| Other current assets | 4.0—15.8% | 4.0+502%15.8% | 1.6+135%3.5% | 0.3+2385%0.2% | 0.1−91.1%0.1% | 0.7−36.1%2.9% | 0.7−36.6%3.0% | 0.0r0.6−99.0%0.0% | 1.0+7.7%3.5% | 1.0—3.4% | 1.0—4.3% | 1.4—5.8% | 1.0—3.0% | |
| Current assets | 11—41.9% | 11−20.1%41.9% | 11−14.9%24.9% | 8.7−55.9%6.7% | 18−15.0%24.4% | 13−38.2%58.2% | 13−39.3%59.0% | 20−7.5%75.4% | 21−10.8%72.7% | 21—71.0% | 22—89.7% | 21—90.4% | 24—75.5% | |
| Property, plant and equipment | 0.1—0.5% | 0.1−72.2%0.5% | 0.1−66.1%0.3% | 0.1+58.0%0.1% | 0.2−70.8%0.2% | 0.4−48.6%1.8% | 0.4−55.0%1.6% | 0.1r0.3−90.4%0.3% | 0.5−42.4%1.8% | 0.8—2.7% | 0.8—3.2% | 0.8—3.6% | 0.9—2.8% | |
| Right-of-use (leased) assets | 0.3—1.3% | 0.3−78.2%1.3% | 0.4−76.8%0.8% | 0.4+122%0.3% | 0.4−71.6%0.6% | 1.5−1.0%6.5% | 1.5+112%6.7% | 0.2r1.3−55.3%0.7% | 1.4+54.7%4.9% | 1.5—5.0% | 0.7—2.9% | 0.4—1.6% | 0.9—3.0% | |
| Goodwill | — | — | — | — | — | 4.7+105%20.7% | 4.5—20.2% | 2.0—7.6% | 2.2—7.3% | 2.3—7.6% | — | 0—0.0% | 0—0.0% | |
| Other intangible assets | — | — | — | — | — | 2.7−32.6%12.0% | 2.7+196%12.0% | 2.7+190%10.5% | 3.8−30.3%12.9% | 4.0—13.4% | 0.9—3.7% | 0.9—4.0% | 5.4—17.2% | |
| Long-term investments | — | — | — | — | — | — | — | 0—0.0% | — | — | — | 0—0.0% | 0.2—0.6% | |
| Total assets | 25—100% | 25+11.1%100% | 45+102%100% | 130+397%100% | 74+153%100% | 23−24.7%100% | 22−7.7%100% | 26+11.0%100% | 29−7.3%100% | 30—100% | 24—100% | 24—100% | 32—100% | |
| Accounts payable | 2.2—8.7% | 2.2−42.7%8.7% | 2.5−35.9%5.5% | 2.3−34.8%1.8% | 3.0−55.5%4.0% | 3.8−17.6%16.8% | 3.9−22.7%17.3% | 3.6r5.5−30.1%13.6% | 6.7−0.8%22.7% | 4.6—15.4% | 5.0—20.6% | 5.1—21.6% | 6.7—21.2% | |
| Debt due within a year | 2.4—9.4% | 2.4−13.6%9.4% | 3.1+41.5%6.9% | 2.7+30.9%2.1% | 2.7+20.7%3.6% | 2.8+14.1%12.2% | 2.2−28.4%9.8% | 2.1+7.7%7.9% | 2.2+100%7.6% | 2.4—8.0% | 3.1—12.7% | 1.9—8.2% | 1.1—3.5% | |
| Current liabilities | 11—44.1% | 11−19.6%44.1% | 8.1−35.6%17.9% | 8.6−54.2%6.6% | 8.7−58.4%11.8% | 14−24.9%60.9% | 13−34.8%56.2% | 19+15.7%71.8% | 21+26.0%71.3% | 18—61.1% | 19—79.6% | 16—68.9% | 17—52.5% | |
| Long-term debt | 0.0—0.1% | 0.0−89.6%0.1% | 0.0−86.2%0.1% | 51—39.0% | 0.1—0.1% | 0.3—1.4% | 0.3—1.2% | 0—0.0% | — | — | — | — | — | |
| Lease liabilities (non-current) | 0.2—0.9% | 0.2−88.4%0.9% | 0.3−88.2%0.6% | 0.3+129%0.2% | 0.3−86.3%0.4% | 2.0−18.1%8.7% | 2.1+17.0%9.5% | 0.1r2.0−87.0%0.5% | 2.2+117%7.6% | 2.4—8.0% | 1.8—7.5% | 0.9—4.0% | 1.0—3.3% | |
| Total liabilities | 11—45.1% | 11−39.0%45.1% | 8.4−52.4%18.6% | 60+175%45.8% | 9.1−62.3%12.3% | 19−14.5%82.3% | 18−16.6%78.8% | 22+26.1%82.8% | 24+30.4%82.3% | 22—72.5% | 21—87.1% | 17—72.9% | 18—58.5% | |
| Retained earnings | −339—−1346% | −339—−1346% | −314—−696% | −278—−213% | −168—−227% | −161—−712% | −159—−710% | −158—−603% | −152—−519% | −148—−493% | −146—−600% | −143—−603% | −134—−423% | |
| Shareholders' equity | 14—54.9% | 14+243%54.9% | 37+673%81.4% | 71+1464%54.2% | 65+1428%87.7% | 4.0−45.0%17.7% | 4.8—21.2% | 4.5−29.6%17.2% | 4.3−70.3%14.5% | 7.3—24.3% | — | 6.4—27.1% | 14—45.3% | |
| Minority interests | — | — | — | — | — | — | — | — | 0.9—3.2% | 1.0—3.2% | — | 0—0.0% | −1.2—−3.8% | |
| Total equity | 14—54.9% | 14+243%54.9% | 37+673%81.4% | 71+1464%54.2% | 65+1152%87.7% | 4.0−51.4%17.7% | 4.8+51.6%21.2% | 4.5−29.6%17.2% | 5.2−60.5%17.7% | 8.3—27.5% | 3.1—12.9% | 6.4—27.1% | 13—41.5% | |
| Total liabilities and equity | 25—100% | 25+11.1%100% | 45+102%100% | 130+397%100% | 74+153%100% | 23−24.7%100% | 22−7.7%100% | 26+11.0%100% | 29−7.3%100% | 30—100% | 24—100% | 24—100% | 32—100% | |
| Shares outstanding | 2.4—— | 2.4−89.2%— | 2.4−87.5%— | 1.0+119%— | 0.7−94.7%— | 23+68.8%— | 19+116%— | 0.5r19−94.7%— | 13+162595%— | 13—— | 9.0—— | 8.9—— | 0.0—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 0.0−96.8%0.0% | 0.0*−97.9%0.0% | 0.0−97.8%0.1% | 0.0*−98.1%0.0% | 0.0−12.5%0.1% | 0.2−24.1%2.0% | 0.2+146%2.7% | 0.2*−27.7%2.8% | 0.0r0.2−97.4%0.1% | 0.3—1.6% | 0.1—0.4% | 0.3*—1.6% | 0.3—1.8% | |
| Share-based compensation | 5.2+69.0%13.1% | 1.6+833%11.8% | 2.8+1511%38.1% | 0.3*−86.3%3.5% | 0.5+33.3%5.5% | 0.2+1333%1.8% | 0.2+1620%2.5% | 2.4*+295%30.7% | 0.4+10050%5.6% | 0.0—0.1% | 0.0—0.1% | 0.6*—3.3% | 0.0—0.0% | |
| Cash from operating activities | −5.6—−14.0% | 1.4*—10.1% | −3.8—−52.9% | −3.2*—−33.8% | 0.0r0.1*—0.3% | −2.9r−2.9*—−29.7% | −2.7r−2.7—−38.8% | −1.3*—−17.6% | −2.1*−502%−28.8% | −0.3*—−1.7% | −1.3—−7.4% | −1.1*—−6.3% | 0.5*—3.0% | |
| Capital expenditure | −0.0—−0.1% | 0*—0.0% | 0—0.0% | −0.0*—−0.3% | −0.0*—−0.1% | −0.1*—−0.7% | −0.0—−0.3% | 0*—0.0% | −0.0*—−0.3% | −0.0*—−0.2% | −0.1—−0.5% | — | −0.0*—−0.0% | |
| Acquisitions, net of cash acquired | — | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | 0*—0.0% | |
| Cash from investing activities | −2.8—−6.9% | 0*—0.0% | 0−100%0.0% | −2.8*—−30.1% | 0.1r−0.0*−76.3%0.6% | −1.1r−1.1*−2051%−11.1% | 0.4r0.4—5.4% | 0*−100%0.0% | 0.2*—3.3% | 0.1*—0.4% | −0.1—−0.5% | 0.0*—0.2% | −0.1*—−0.4% | |
| Debt issued | 2.5−62.9%6.3% | 0.9*−48.2%6.4% | 1.6+48.6%22.1% | −1.5*−195%−16.2% | 1.6*−35.7%15.9% | 1.7*+28.0%17.3% | 1.1−64.8%15.8% | 1.6r8.1*+67.1%20.9% | 2.4r−0.3*—33.3% | 1.3r−2.5*—8.4% | 3.1—17.1% | 1.0r0.8*—5.3% | −0.1r−0.0*—−0.5% | |
| Debt repaid | — | −1.6*—−11.7% | −1.2—−15.9% | — | −1.5*—−15.7% | −1.3*—−13.0% | −1.1—−15.8% | −1.6*—−21.2% | −2.7*—−36.9% | −2.0*—−12.5% | −1.9—−10.5% | −0.1*—−0.3% | −0.1*—−0.3% | |
| Shares issued | 15+177%37.5% | 0*−100%0.0% | 0.1—1.6% | 1.5*−65.5%15.7% | 13*—138% | 1.2*—11.9% | 0—0.0% | 4.3*—55.9% | 0*−100%0.0% | — | — | 0*—0.0% | 2.7*—15.8% | |
| Shares bought back | — | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | 0*—0.0% | |
| Cash from financing activities | 9.7+109%24.2% | −0.7*−148%−5.3% | 0.6—7.8% | −0.7*−121%−7.7% | 11*—108% | 1.5*−66.8%15.6% | 0—0.0% | 3.4*+381%44.2% | −0.3*−111%−3.6% | 4.6r2.2*—29.1% | −1.2r1.2—−6.6% | 0.7*—3.9% | 2.3*—13.5% | |
| Change in cash | 2.3—5.7% | 0.7*—4.8% | −3.3—−45.6% | −7.5*−515%−80.2% | 12*—127% | −2.2*−212%−22.7% | −2.3—−34.1% | 1.8*—23.6% | −1.9*−161%−26.5% | 2.0*—12.6% | −0.2—−1.1% | −0.4*—−2.3% | 3.1*—18.2% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Where ZeroStack Corp. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 2 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office1 subsidiary | — |
| 🇩🇪 Germany | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Events at ZeroStack Corp.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 2 · Auditor changed 1 · Acquisition or sale completed 4 · Directors and officers 11 · Material agreement 12 · Agreement ended 4 · New debt 1 · Unregistered share sale 7 · Shareholder rights changed 1 · Bylaws or fiscal year changed 3 · Shareholder vote 3
| Filed | What happened | Filing |
|---|---|---|
| Auditor changed | 8-K | |
| Material agreement | 8-K | |
| Directors and officersMaterial agreementAgreement ended | 8-K | |
| Acquisition or sale completedDirectors and officersMaterial agreementUnregistered share sale | 8-K | |
| Acquisition or sale completed | 8-K | |
| Directors and officersBylaws or fiscal year changedShareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Material agreementAgreement endedUnregistered share sale | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Directors and officers | 8-K | |
| Material agreementAgreement endedUnregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Acquisition or sale completedDirectors and officersMaterial agreementNew debtUnregistered share sale | 8-K | |
| Material agreement | 8-K | |
| Delisting noticeDirectors and officers | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Delisting notice | 8-K | |
| Acquisition or sale completedMaterial agreementUnregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Material agreement | 8-K | |
| Material agreement | 8-K | |
| Agreement ended | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2026 | $1.0 B | Private placement after listing | $1 billion or more | 2 | equity, options | SEC |
| Jul 2026 | $92 M | Private placement after listing | $50 to $250 million | 24 | equity | SEC |
| Sep 2025 | $25 M | Private placement after listing | $10 to $50 million | 18 | options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How ZeroStack Corp. compares in Pharmaceutical
- Market cap$51 M · higher than 13% of 393
- Revenue$36 M · higher than 12% of 324
- Net margin-444.3% · higher than 2% of 313
- Revenue growth-0.5% · higher than 25% of 107
- Price / sales1.3× · lower than 77% of 219
- Price / book0.7× · lower than 91% of 207
- FCF yield-17.2% · higher than 19% of 69
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| ZeroStack Corp.🇺🇸 | $51 M | — | -444.3% | -0.5% |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Korea United Pharm Inc.$191 M
- Suheung Co., Ltd.$199 M
- JW Holdings Corporation$206 M
- Hester Biosciences Limited$214 M
- Venus Remedies Limited$215 M
- Windlas Biotech Limited$217 M
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at ZeroStack Corp.? Verify and update this profile — free
Show ZeroStack Corp.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.